Evolutionary and Functional Analysis of the Key Pluripotency Factor Oct4 and Its Family Proteins

Total Page:16

File Type:pdf, Size:1020Kb

Evolutionary and Functional Analysis of the Key Pluripotency Factor Oct4 and Its Family Proteins Available online at www.sciencedirect.com JGG Journal of Genetics and Genomics 40 (2013) 399e412 ORIGINAL RESEARCH Evolutionary and Functional Analysis of the Key Pluripotency Factor Oct4 and Its Family Proteins Xinmin Zhang a,1, Yuzhen Ma e,1, Xiuying Liu b,d, Qi Zhou c,*, Xiu-Jie Wang b,* a Computer & Information Engineering College, Inner Mongolia Normal University, Inner Mongolia, Hohhot 010022, China b State Key Laboratory of Plant Genomics, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing 100101, China c State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China d University of Chinese Academy of Sciences, Beijing 100101, China e Centre of Reproductive Medicine, Inner Mongolia Hospital, Inner Mongolia, Hohhot 010017, China Received 28 March 2013; revised 14 April 2013; accepted 15 April 2013 Available online 13 June 2013 ABSTRACT Oct4 is one of the key pluripotent factors essential for embryonic stem cells and induced pluripotent stem (iPS) cells. Oct4 belongs to the POU domain family, which contains multiples genes with various important functions. Although the function of Oct4 has been extensively studied, detailed comparison of Oct4 with other POU family genes and their evolutionary analysis are still lacking. Here, we systematically identified POU family genes from lower to higher animal species. We observed an expansion of POU family genes in vertebrates, with an additional increment in mammalian genomes. We analyzed the phylogenetic relationship, tissue specific expression profiles and regulatory networks of POU family genes of the human genome, and predicted the putative binding microRNAs of human POU family genes. These results provide the first comprehensive evolutionary and comparative analysis of POU family genes, which will help to better understand the relationships among POU family genes and shed light on their future functional studies. KEYWORDS: Oct4; Induced pluripotent stem cell; POU family; MicroRNA; Evolutionary analysis INTRODUCTION implantation (Pesce and Scholer, 2001). Oct4 shares a sub- stantial fraction of target genes with the other key pluripotent Oct4 is a key transcription factor regulating the pluripotency regulatory factors, namely Sox2 and Nanog. Genes co- of embryonic stem cells. By cooperating with other proteins, regulated by these three factors and with functions in pluripo- Oct4 plays essential roles in the establishment and maintenance tency maintenance are actively transcribed in ES cells, whereas of pluripotency in embryonic stem (ES) cells (Babaie et al., those regulating differentiation and development are tran- 2007). Endogenous Oct4 is initially activated as a maternal scriptionally repressed (Loh et al., 2006). Oct4 is the central factor in oocytes and remains active in embryos throughout the factor for the generation of induced pluripotent stem (iPS) cells pre-implantation period (Looijenga et al., 2003). The expres- (Zhao et al., 2009; Wang et al., 2012a, 2012b). Overexpression sion of Oct4 decreases during the trophoblast differentiation of Oct4 with other key transcription factors, typically Sox2, process and remains only in primordial germ cells after Klf4 and c-Myc, can convert differentiated somatic cells back to the embryonic stem cell-like stage (Yamanaka and Blau, 2010). Among these reprogramming factors, Oct4 seems to be indis- þ þ * Corresponding authors. Tel: 86 10 6480 6590, fax: 86 10 6480 6595 pensable for high efficient iPS cell production (Shi and Jin, (X.-J. Wang); Tel: þ86 10 6480 7299, fax: þ86 10 6480 7858 (Q. Zhou). E-mail addresses: [email protected] (Q. Zhou); [email protected] 2010). (X.-J. Wang). Oct4 belongs to the Octamer transcription factor family 0 0 1 These authors contributed equally to this work. which binds to the consensus 5 -ATTTGCAT-3 motif, and 1673-8527/$ - see front matter Copyright Ó 2013, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, and Genetics Society of China. Published by Elsevier Limited and Science Press. All rights reserved. http://dx.doi.org/10.1016/j.jgg.2013.04.011 400 X. Zhang et al. / Journal of Genetics and Genomics 40 (2013) 399e412 hence it is named as “Oct”. The Oct4 protein contains the interferon-induced transcriptional responses (Hofmann et al., homeodomain and POU domains (Hammachi et al., 2012). 2010). The other POU domain class 3 factors, namely The homeodomain is a protein structural domain binding DNA POU3F2, POU3F3 and POU3F4, are all brain-specific homeo- or RNA, and is thus commonly found in transcription factors box factors with neuronal development related functions (Urrutia, 1997). The name of POU domain is derived from the (Andersen and Rosenfeld, 2001). Similar to the POU3 class names of pituitary-specific domain, Octamer transcription proteins, the POU domain class 4 factors also mainly function in factor domain and neural Unc-86 transcription factor domain regulating the development of sensory nervous system (Erkman from Caenorhabditis elegans. The human genome contains et al., 1996; McEvilly et al., 1996). Besides Oct4, the POU many POU family proteins. They were grouped into 6 classes domain class 5 also contains two other members. POU5F1B is a according to their sequence similarities. Oct4 belongs to the processed pseudogene of Oct4 and may also play roles in the class 5 of POU domain transcription factors, and therefore is regulation of cell pluripotency and cancer development also named as POU5F1. (Crowther-Swanepoel et al., 2010; Kastler et al., 2010). Another The various members of the POU family have a wide variety member of the POU domain class 5 genes is POU5F2, whose of functions, mainly related to the regulation of the neuroen- function is unconfirmed yet. The POU domain class 6 proteins docrine system (Assa-Munt et al., 1993) and the development of are less studied, both members mainly function in brain and may an organism (Andersen and Rosenfeld, 2001). The member of also be implicated in the development of certain cancers (Perotti the POU domain class 1, POU1F1 (Pit1), is expressed in pitui- et al., 2004; Zhang et al., 2011). tary and serves as the key regulator for human growth hormone Although the importance of Oct4 in regulating embryonic expression (Hunsaker et al., 2012). POU2F1, also known as stem cell pluripotency and inducing somatic cell reprogram- Oct1, is ubiquitously expressed in both embryonic and adult ming has been well recognized, systematic analysis on the mouse tissues, and has multiple functions in growth regulation POU family proteins through the evolutionary point of view is and disease development (Sreenivasan and Viljoen, 2013). still lacking. Here, we performed genome-wide identification POU2F2 (Oct2) is a key factor for B-cells, functioning by of POU family members in 10 animal species. With the pri- directly activating the anti-apoptotic gene bcl-2 (Heckman et al., mary focus of the POU family proteins in human, we sys- 2006). POU3F1 (Oct6) is essential for terminal myelination of tematically studied their domain structure, evolutionary Schwann cells (Ryu et al., 2007) and can be involved in conservation, expression profile, interacting network and Fig. 1. Phylogenetic tree of the 10 studied species and the numbers of POU family genes in each species. Numbers in red represent the identified POU family genes. The names of studied species are shown in italic type, and the classification information of species is shown in bold. X. Zhang et al. / Journal of Genetics and Genomics 40 (2013) 399e412 401 relationship with microRNAs (miRNAs). These findings will genome sequences in this work, including Caenorhabditis be helpful for a thorough functional understanding of the POU elegans, Drosophila melanogaster, zebrafish, chicken, cow, family members. pig, mouse, rat, chimpanzee and human (Fig. 1). By searching for proteins with identifiable POU domain and sequence ho- RESULTS mology to the Oct4 protein, genes encoding POU family proteins were identified in these species. In nematode Identification of POU family genes in 10 species C. elegans and the arthropod D. melanogaster, only one POU family gene was found in each of their genomes. However, a To systematically identify POU family genes in animals, big expansion of the POU family genes occurred in verte- we selected 10 commonly studied species with complete brates, with 8 POU family genes in the zebrafish genome, 9 A NP_000297 (POU1F1 isoform alpha) NP_001116229 (POU1F1 isoform beta) NP_002688 (POU2F1 isoform1) NP_001185712 (POU2F1 isoform2) NP_001185715 (POU2F1 isoform3) NP_001193954 (POU2F2 isoform1) NP_002689 (POU2F2 isoform2) NP_001193955 (POU2F2 isoform3) NP_001234923 (POU2F2 isoform4) NP_055167 (POU2F3 isoform1) NP_001231611 (POU2F3 isoform2) NP_002690 (POU3F1) NP_005595 (POU3F2) NP_006227 (POU3F3) NP_000298 (POU3F4) NP_006228 Pou (POF4F1) NP_004566 Homeobox (POU4F2) NP_002691 (POU4F3) Lsr2 NP_002692 (POU5F1 isoform1) DUF1183 NP_976034 (POU5F1 isoform2) NP_001153014 DUF521 (POU5F1B) NP_694948 (POU5F2) NP_002693 (POU6F1) NP_009183 (POU6F2 isoform1) NP_001159490 (POU6F2 isoform2) Fig. 2. Domain analysis of POU family proteins. A: domain composition and distribution of human POU family proteins. B: domain composition and distribution of Oct4 protein in 10 studied species. 402 X. Zhang et al. / Journal of Genetics and Genomics 40 (2013) 399e412 B [1] Homo sapiens: Pou NP_002692 [2] Pan troglodytes: Homeobox XP_001135162 [3] Sus scrofa: DUF521 NP_001106531 [4] Bos taurus: NP_777005 [5] Rattus
Recommended publications
  • Genome-Wide Association Analysis Reveal the Genetic Reasons Affect Melanin Spot Accumulation in Beak Skin of Ducks
    Genome-wide association analysis reveal the genetic reasons affect melanin spot accumulation in beak skin of ducks Hehe Liu Sichuan Agricultural University Jianmei Wang Sichuan Agricultural University Jian Hu Chinese Academy of Agricultural Sciences Lei Wang Sichuan Agricultural University Zhanbao Guo Chinese Academy of Agricultural Sciences Wenlei Fan Chinese Academy of Agricultural Sciences Yaxi Xu Chinese Academy of Agricultural Sciences Dapeng Liu Chinese Academy of Agricultural Sciences Yunsheng Zhang Chinese Academy of Agricultural Sciences Ming Xie Chinese Academy of Agricultural Sciences Jing Tang Chinese Academy of Agricultural Sciences Wei Huang Chinese Academy of Agricultural Sciences Qi Zhang Chinese Academy of Agricultural Sciences Zhengkui Zhou Chinese Academy of Agricultural Sciences Shuisheng Hou ( [email protected] ) Chinese Academy of Agricultural Sciences Page 1/21 Research Article Keywords: skin melanin spot, duck, GWAS, genetic Posted Date: June 25th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-608516/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 2/21 Abstract Background Skin pigmentation is a broadly appearing phenomenon of most animals and humans in nature. Here we used a bird model to investigate why melanin spot deposits on the skin. Results We result shown that melanin deposition in bird skin was induced by growth age and ultraviolet UV radiation and determined by genetic factors. GWAS helped us to identify two major loci affecting melanin deposition, located on chromosomes 13 and 25, respectively. Fine mapping works narrowed the candidate regions to 0.98 Mb and 1.0 Mb on chromosome 13 and 25, respectively.
    [Show full text]
  • POU Domain Family Values: Flexibility, Partnerships, and Developmental Codes
    Downloaded from genesdev.cshlp.org on October 1, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW POU domain family values: flexibility, partnerships, and developmental codes Aimee K. Ryan and Michael G. Rosenfeld 1 Howard Hughes Medical Institute, Department and School of Medicine, University of California at San Diego, La Jolla, Califiornia 92093-0648 USA Transcription factors serve critical roles in the progres- primary focus of this review. Crystallization of the Oct-1 sive development of general body plan, organ commit- and Pit-1 POU domains on DNA and in vitro studies ment, and finally, specific cell types. It has been the hope examining the specificity of POU domain cofactor inter- of most developmental biologists that comparison of the actions suggest that the flexibility with which the POU biological roles of a series of individual members within domain recognizes DNA-binding sites is a critical com- a family will permit at least some predictive generaliza- ponent of its ability to regulate gene expression. The tions regarding the developmental events that are likely implications of these data with respect to the mecha- to be regulated by a particular class of transcription fac- nisms utilized by the POU domain family of transcrip- tors. Here, we present an overview of the developmental tion factors to control developmental events will also be functions of the family of transcription factors charac- discussed. terized by the POU DNA-binding motif afforded by re- cent in vivo studies. Conformation of the POU domain on DNA The POU domain family of transcription factors was defined following the observation that the products of High-affinity site-specific DNA binding by POU domain three mammalian genes, Pit-l, Oct-l, and Oct-2 and the transcription factors requires both the POU-specific do- protein encoded by the Caenorhabditis elegans gene main and the POU homeodomain (Sturm and Herr 1988; unc-86 shared a region of homology, known as the POU Ingraham et al.
    [Show full text]
  • POU2F3 (NM 014352) Human Tagged ORF Clone Product Data
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for RC210969L1 POU2F3 (NM_014352) Human Tagged ORF Clone Product data: Product Type: Expression Plasmids Product Name: POU2F3 (NM_014352) Human Tagged ORF Clone Tag: Myc-DDK Symbol: POU2F3 Synonyms: Epoc-1; OCT-11; OCT11; OTF-11; PLA-1; PLA1; Skn-1a Vector: pLenti-C-Myc-DDK (PS100064) E. coli Selection: Chloramphenicol (34 ug/mL) Cell Selection: None ORF Nucleotide The ORF insert of this clone is exactly the same as(RC210969). Sequence: Restriction Sites: SgfI-MluI Cloning Scheme: ACCN: NM_014352 ORF Size: 1308 bp This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 2 POU2F3 (NM_014352) Human Tagged ORF Clone – RC210969L1 OTI Disclaimer: The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info OTI Annotation: This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. RefSeq: NM_014352.1 RefSeq Size: 3013 bp RefSeq ORF: 1311 bp Locus ID: 25833 UniProt ID: Q9UKI9 MW: 47.4 kDa Gene Summary: This gene encodes a member of the POU domain family of transcription factors.
    [Show full text]
  • Small Cell Lung Cancer: State of the Art of the Molecular and Genetic Landscape and Novel Perspective
    cancers Review Small Cell Lung Cancer: State of the Art of the Molecular and Genetic Landscape and Novel Perspective Valeria Denninghoff 1 , Alessandro Russo 2,3 , Diego de Miguel-Pérez 2 , Umberto Malapelle 4 , Amin Benyounes 5, Allison Gittens 2, Andres Felipe Cardona 6,7,8 and Christian Rolfo 2,* 1 National Council for Scientific and Technical Research (CONICET), University of Buenos Aires, Buenos Aires C1122AAH, Argentina; [email protected] 2 Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD 21201, USA; [email protected] (A.R.); [email protected] (D.d.M.-P.); [email protected] (A.G.) 3 Medical Oncology Unit, A.O. Papardo, 98158 Messina, Italy 4 Department of Public Health, University of Naples Federico II, 80138 Naples, Italy; [email protected] 5 Thoracic Oncology, Inova Schar Cancer Center, Fairfax, VA 22031, USA; [email protected] 6 Clinical and Translational Oncology Group, Clínica del Country, Bogotá 110221, Colombia; [email protected] 7 Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá 110111, Colombia 8 Molecular Oncology and Biology Systems Research Group (Fox-G/ONCOLGroup), Universidad el Bosque, Bogotá 110121, Colombia * Correspondence: [email protected]; Tel.: +1-(410)-328-7224 Citation: Denninghoff, V.; Russo, A.; Simple Summary: Small cell lung cancer (SCLC) continues to carry a poor prognosis with a five-year de Miguel-Pérez, D.; Malapelle, U.; survival rate of 3.5% and a 10-year survival rate of 1.8%. The pathogenesis remains unclear, and Benyounes, A.; Gittens, A.; Cardona, there are no known predictive or diagnostic biomarkers.
    [Show full text]
  • Lineage Transcription Factors Co-Regulate Subtype-Specific Genes Providing a Roadmap For
    bioRxiv preprint doi: https://doi.org/10.1101/2020.08.13.249029; this version posted August 14, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Lineage transcription factors co-regulate subtype-specific genes providing a roadmap for systematic identification of small cell lung cancer vulnerabilities Karine Pozo1,2, Rahul K. Kollipara3, Demetra P. Kelenis1, Kathia E. Rodarte1, Xiaoyang Zhang4, John D. Minna5,6,7,8 and Jane E. Johnson1,6,8 1Department of Neuroscience, 2Department of Surgery, 3McDermott Center for Human Growth and Development, UT Southwestern Medical Center, Dallas, TX 75390, USA 4Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 5Hamon Center for Therapeutic Oncology Research, 6Simmons Comprehensive Cancer Center, 7Department of Internal Medicine, 8Department of Pharmacology, UT Southwestern Medical Center, Dallas, TX 75390, USA JDM receives licensing fees for lung cancer lines from the NIH and UT Southwestern. 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.08.13.249029; this version posted August 14, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. ABSTRACT Lineage-defining transcription factors (LTFs) play key roles in tumor cell growth, making them highly attractive, but currently “undruggable”, small cell lung cancer (SCLC) vulnerabilities.
    [Show full text]
  • POU2F3 Rabbit Polyclonal Antibody – TA330590 | Origene
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for TA330590 POU2F3 Rabbit Polyclonal Antibody Product data: Product Type: Primary Antibodies Applications: IHC, WB Recommended Dilution: WB, IHC Reactivity: Human, Mouse, Rat Host: Rabbit Isotype: IgG Clonality: Polyclonal Immunogen: The immunogen for anti-POU2F3 antibody: synthetic peptide directed towards the N terminal of human POU2F3. Synthetic peptide located within the following region: KMSGDVADSTDARSTLSQVEPGNDRKGLDFNRQIKTEDLSDSLQQTLSHR Formulation: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose. Note that this product is shipped as lyophilized powder to China customers. Conjugation: Unconjugated Storage: Store at -20°C as received. Stability: Stable for 12 months from date of receipt. Predicted Protein Size: 47 kDa Gene Name: POU class 2 homeobox 3 Database Link: NP_055167 Entrez Gene 18988 MouseEntrez Gene 116544 RatEntrez Gene 25833 Human Q9UKI9 Background: POU domain genes encode a family of highly conserved transacting factors that influence the transcriptional activity of several cell type-specific and ubiquitous genes. Synonyms: Epoc-1; OCT-11; OCT11; OTF-11; PLA-1; PLA1; Skn-1a Note: Dog: 100%; Pig: 100%; Rat: 100%; Human: 100%; Mouse: 100%; Sheep: 100%; Rabbit: 100%; Guinea pig: 100%; Zebrafish: 77% This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 3 POU2F3 Rabbit Polyclonal Antibody – TA330590 Product images: WB Suggested Anti-POU2F3 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1:312500; Positive Control: HepG2 cell lysate Human Muscle This product is to be used for laboratory only.
    [Show full text]
  • POU2F3 Is a Master Regulator of a Tuft Cell-Like Variant of Small Cell Lung Cancer
    Downloaded from genesdev.cshlp.org on October 9, 2021 - Published by Cold Spring Harbor Laboratory Press POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer Yu-Han Huang,1 Olaf Klingbeil,1 Xue-Yan He,1 Xiaoli S. Wu,1,2 Gayatri Arun,1 Bin Lu,1 Tim D.D. Somerville,1 Joseph P. Milazzo,1 John E. Wilkinson,3 Osama E. Demerdash,1 David L. Spector,1 Mikala Egeblad,1 Junwei Shi,4 and Christopher R. Vakoc1 1Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA; 2Genetics Program, Stony Brook University, Stony Brook, New York 11794, USA; 3Department of Pathology, University of Michigan School of Medicine, Ann Arbor, Michigan 48109, USA; 4Department of Cancer Biology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA Small cell lung cancer (SCLC) is widely considered to be a tumor of pulmonary neuroendocrine cells; however, a variant form of this disease has been described that lacks neuroendocrine features. Here, we applied domain-focused CRISPR screening to human cancer cell lines to identify the transcription factor (TF) POU2F3 (POU class 2 homeobox 3; also known as SKN-1a/OCT-11) as a powerful dependency in a subset of SCLC lines. An analysis of human SCLC specimens revealed that POU2F3 is expressed exclusively in variant SCLC tumors that lack expres- sion of neuroendocrine markers and instead express markers of a chemosensory lineage known as tuft cells. Using chromatin- and RNA-profiling experiments, we provide evidence that POU2F3 is a master regulator of tuft cell identity in a variant form of SCLC.
    [Show full text]
  • Integrated Genomics and Therapeutics Predictors of Small
    bioRxiv preprint doi: https://doi.org/10.1101/2020.03.09.980623; this version posted April 7, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license. 1 SCLC_CellMiner: Integrated Genomics and Therapeutics Predictors of Small Cell Lung 2 Cancer Cell Lines based on their genomic signatures 3 4 Camille Tlemsani1,†,*, Lorinc Pongor1,†, Luc Girard4, Nitin Roper1, Fathi Elloumi1, Sudhir 5 Varma1, Augustin Luna5, Vinodh N. Rajapakse1, Robin Sebastian1, Kurt W. Kohn1, Julia 6 Krushkal2, Mirit Aladjem1, Beverly A. Teicher2, Paul S. Meltzer3, William C. Reinhold1, John D. 7 Minna4, Anish Thomas1 and Yves Pommier1, 6 8 9 1 Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for 10 Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA 11 12 2 Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer 13 Institute, NIH, 9609 Medical Center Dr., Rockville, MD 20850, USA 14 15 3 Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, 16 USA 17 18 4 Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, 19 TX 75390, USA 20 21 5 cBio Center, Division of Biostatistics, Department of Data Sciences, Dana-Farber Cancer 22 Institute, Boston, MA 02115, USA 23 24 6 To whom correspondence should be addressed: 25 [email protected] 26 27 * present address, INSERM U1016, Cochin Institute, Paris Descartes University, 75014 Paris 28 29 † Contributed equally to the study 30 31 32 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.03.09.980623; this version posted April 7, 2020.
    [Show full text]
  • Qt7s99h7j8 Nosplash 33D25b6
    ! ii! Acknowledgements Lots of people have helped me get to where I am today and I apologize if I have left anyone out. First, I would like to thank my mother and father for always pushing me to try harder and encouraging me to persist in my scientific career. Both of my parents encouraged me to think like a scientist from a young age. I don’t think I would be here today without that early upbringing. Joining the Pollard lab was the best decision I made in graduate school. I can’t emphasize the importance of finding a good mentor in school. My advisor, Katherine Pollard, provided me with a model of leadership that I will carry with me for the rest of my career. Additionally, I would like to emphasize that the lab is full of driven individuals that have supported me in all my scientific endeavors. Fellow graduate students, Aram Avila-Herrera and Genevieve Erwin Haliburton, guided much of my direction during the early years. In addition, postdoctoral scholars Nandita Garud, Hassan Samee, Patrick Bradley, and Geoffrey Fudenberg were key in helping me prepare for my future steps in my career. I want to thank my committee members for sitting through long meetings and giving me the feedback I needed. Nadav Ahituv, Benoit Bruneau, and Jeff Wall have given me valuable advice on whether to pursue certain directions in my research. I also want to acknowledge all the individuals that supported me personally in school. In particular, I have always valued Sara Calhoun’s well-thought-out advice and Rose ! iii! Citron’s insight when making important decisions.
    [Show full text]
  • ©Ferrata Storti Foundation
    Acute Lymphoblastic Leukemia • Research Paper Novel cryptic chromosomal rearrangements in childhood acute lymphoblastic leukemia detected by multiple color fluorescent in situ hybridization Bruce Poppe Background and Objectives. It is often difficult to obtain good karyotypes of cells from Barbara Cauwelier children with acute lymphoblastic leukemia (ALL) because of poor morphology and Heidi Van Limbergen spreading. Detailed karyotyping can be further hampered by the presence of multiple Nurten Yigit rearrangements. Our objective was to search for cryptic rearrangements in childhood ALL. Jan Philippé Design and Methods. A series of eight cases of childhood ALL with at least two structur- Bruno Verhasselt al defects were selected and studied by multiple color fluorescent in situ hybridization (M- Anne De Paepe FISH). Yves Benoit Frank Speleman Results. Four previously not reported translocations were detected: a t(14;20) (q32;q11.2) in a 3-year old girl with T-ALL, a cryptic t(7;11)(q35;q24) in association with a t(1;14)(p32;q32) in a patient with T-ALL and two translocations possibly involving the same 6q26 region on the distal end of the long arm of chromosome 6. Further FISH analysis on the t(7;11) indicated rearrangement of the TCRB locus at 7q35 suggesting that this t(7;11) leads to overexpression of an as yet unidentified gene at 11q24. This observation also triggered further screening for TCRB rearrangements in T-ALL. FISH analysis of the t(14;20) with an IGH locus-specific probe provided evidence for an unusu- al rearrangement of the IGH gene, in the variable gene segment region.
    [Show full text]
  • Integrative Analysis of Multi-Omics Data Reveals the Heterogeneity and Signatures of Immune Therapy for Small Cell Lung Cancer
    Integrative analysis of multi-omics data reveals the heterogeneity and signatures of immune therapy for small cell lung cancer Yabin Chen Shanghai Tech University Zhaoyuan Fang Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences https://orcid.org/0000-0002-0393-2052 Ying Tang Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences Yujuan Jin State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences Chenchen Guo Institute of Biochemistry and CState Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellell Biology, Shanghai Institutes for Biological Sciences, C Liang Hu State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences Yang Xu Chinese PLA General Hospital Jie Gao Chinese PLA General Hospital Mei Xie Aliated Zhongshan Hospital of Dalian University Xuelai Zang Chinese PLA General Hospital Xi Ma Chinese PLA General Hospital Sanhong Liu Shanghai University of Traditional Chinese Medicine Haiquan Chen Fudan University Shanghai Cancer Center Xinying Xue Chinese PLA General Hospital Hongbin Ji State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences https://orcid.org/0000-0003-0891-6390 Luonan Chen ( [email protected] ) Institute of Biochemistry and CState Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellell Biology, Shanghai Institutes for Biological Sciences, C Page 1/18 Article Keywords: Small cell lung cancer, network modules, tumor heterogeneity, immune subtype, immunotherapy Posted Date: January 22nd, 2021 DOI: https://doi.org/10.21203/rs.3.rs-148857/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License.
    [Show full text]
  • Subtype-Specific Secretomic Characterization of Pulmonary
    ARTICLE https://doi.org/10.1038/s41467-019-11153-5 OPEN Subtype-specific secretomic characterization of pulmonary neuroendocrine tumor cells Xu-Dong Wang 1, Rongkuan Hu1, Qing Ding1, Trisha K. Savage 2, Kenneth E. Huffman3, Noelle Williams1, Melanie H. Cobb3,4, John D. Minna3,4,5,6, Jane E. Johnson 2,3,4 & Yonghao Yu1 Pulmonary neuroendocrine (NE) cancer, including small cell lung cancer (SCLC), is a parti- cularly aggressive malignancy. The lineage-specific transcription factors Achaete-scute 1234567890():,; homolog 1 (ASCL1), NEUROD1 and POU2F3 have been reported to identify the different subtypes of pulmonary NE cancers. Using a large-scale mass spectrometric approach, here we perform quantitative secretome analysis in 13 cell lines that signify the different NE lung cancer subtypes. We quantify 1,626 proteins and identify IGFBP5 as a secreted marker for ASCL1High SCLC. ASCL1 binds to the E-box elements in IGFBP5 and directly regulates its transcription. Knockdown of ASCL1 decreases IGFBP5 expression, which, in turn, leads to hyperactivation of IGF-1R signaling. Pharmacological co-targeting of ASCL1 and IGF-1R results in markedly synergistic effects in ASCL1High SCLC in vitro and in mouse models. We expect that this secretome resource will provide the foundation for future mechanistic and biomarker discovery studies, helping to delineate the molecular underpinnings of pulmonary NE tumors. 1 Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas 75390 TX, USA. 2 Department of Neuroscience, University of Texas Southwestern Medical Center, Dallas 75390 TX, USA. 3 Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas 75390 TX, USA. 4 Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas 75390 TX, USA.
    [Show full text]